Quarterly report pursuant to Section 13 or 15(d)

Convertible Debt and Other Debt

v3.19.3.a.u2
Convertible Debt and Other Debt
9 Months Ended
Sep. 30, 2019
Debt Disclosure [Abstract]  
Convertible Debt and Other Debt

6) Convertible Debt and Other Debt

 

Conversion of Notes

 

We issued 5,075.40 shares of our Series AA Convertible Preferred Stock in satisfaction of $12,688,635 of convertible promissory notes, Revolving Note and short-term loans issued:

 

    Debt converted
to stock
 
Current liabilities        
Convertible Debentures, face value   $ 6,962,635  
Revolving Note with interest     4,750,000  
May 19, 2017 Promissory Note with interest     750,000  
Other Notes with interest     226,000  
Total debt converted during the year 2018   $ 12,688,635  

 

Senior Secured Convertible Debentures and Warrants

 

We entered into Subscription Agreements (the “Subscription Agreement”) with various individuals (each, a “Purchaser”) between July 23, 2015 and March 31, 2016, pursuant to which the Company sold Senior Secured Convertible Debentures (the “Debentures”) and warrants to purchase shares of common stock equal to 50% of the number of shares issuable pursuant to the subscription amount (the “Warrants”) for an aggregate purchase price of $6,329,549 (the “Purchase Price”).

 

The Company issued a principal aggregate amount of $6,962,504 in Debentures which includes a 10% original issue discount on the Purchase Price. The Debenture does not accrue any additional interest during the first year it is outstanding but accrues interest at a rate equal to 10% per annum for the second year it is outstanding. The Debenture has a maturity date of two years from issuance. The Debenture is convertible any time after its issuance date. The Purchaser has the right to convert the Debenture into shares of the Company’s common stock at a fixed conversion price equal to $8.40 per share, subject to applicable adjustments. In the second year that the Debenture is outstanding, any interest accrued shall be payable quarterly in either cash or common stock, at the Company’s discretion. On September 11, 2017, we notified Debenture holders that their Debentures will be extended 180 days beyond the original maturity date as permitted in the Debenture agreement. We will continue to pay interest on the Debentures until the extended maturity date. We accounted for the Debenture extensions as debt modifications and not extinguishment of debt since the changes in fair value are not substantial in accordance with ASC 470-50. We started amortizing the remaining unamortized discount as of September 11, 2017 over the new term, which extends 180 days beyond the original maturity date.

 

In connection with the Debentures issued, the Company issued warrants exercisable into a total of 376,759 shares of our common stock. The Warrants issued in this transaction are immediately exercisable at an exercise price of $12.00 per share, subject to applicable adjustments including full ratchet anti-dilution if we issue any securities at a price lower than the exercise price then in effect. The Warrants have an expiration period of five years from the original issue date. The Warrants are subject to adjustment for stock splits, stock dividends or recapitalizations and also include anti-dilution price protection for subsequent equity sales below the exercise price.

 

On May 2, 2018, the Company entered into a Securities Purchase Agreement with an existing shareholder pursuant to which the Company sold an aggregate of 100 shares of Series AA Convertible Preferred Stock for an aggregate Purchase Price of $250,000. We issued to the shareholder a new warrant to purchase 100,000 shares of common stock with an exercise price of $3.50 per share and an expiration period of five years from the original issue date.

 

The Company, pursuant to a price protection provision triggered on May 2, 2018 with the sale of Series AA Convertible Preferred Stock, amended the Debentures and Warrants to purchase Common Stock held by the Debenture Holders entered into between July 22, 2015 and March 31, 2016 as first disclosed in the Company’s Current Report on Form 8-K filed on July 28, 2015. The fair value of $207,899 relating to the reduction in exercise price was treated as a deemed dividend and recorded as a charge against additional paid-in capital within equity. The amended Debenture conversion price was exempt from revaluation because a beneficial conversion feature had already been recorded on the Debenture at issuance.

 

Subject to the terms and conditions of the Warrants, at any time commencing six months from the Final Closing, the Company has the right to call the Warrants for cancellation if the volume weighted average price of its Common Stock on the OTCQB (or other primary trading market or exchange on which the Common Stock is then traded) equals or exceeds three times the per share exercise price of the Warrants for 15 out of 20 consecutive trading days.

 

In connection with the Subscription Agreement and Debenture, the Company entered into Security Agreements with the Purchasers whereby the Company agreed to grant to Purchasers an unconditional and continuing, first priority security interest in all of the assets and property of the Company to secure the prompt payment, performance and discharge in full of all of Company’s obligations under the Debentures, Warrants and the other Transaction Documents. On May 14 and June 11, 2018, the Company signed letter agreements with the Debenture holders as explained below that discharged all of the Company’s obligations within the Debenture Agreement

 

Conversion of Debentures

 

On May 14, 2018, we entered into letter agreements (the “Letter Agreements”) with 22 investors (each a “Debenture Holder” and together the “Debenture Holders”) holding convertible debentures (collectively the “Debentures”) and warrants to purchase common stock (the “Debenture Warrants”) whereby the Debenture Holders agreed to convert a total of $6,220,500 in principal and original issue discount due them under the Debentures into 2,448.20 shares of Series AA Convertible Preferred Stock with a conversion price of $2.50 per share. The Debenture Holders were also: (a) issued amended Debenture Warrants such that the exercise price will be $3.50 per share; and (b) issued a new warrant with an exercise price of $3.50 per share to purchase 2,448,200 shares of common stock (the number of shares of common stock issuable upon conversion of the Series AA Convertible Preferred Stock shares received as a result of the Debenture conversions). The Debenture Holders also agreed to waive any and all defaults or events of default by the Company with respect to any failure by the Company to comply with any covenants contained in the Debentures. The fair value of $29,865 relating to the adjustment in exercise price was treated as a loan modification and recorded as a gain toward the extinguishment of debt.

 

On June 11, 2018, the Company entered into additional Letter Agreements with 15 Debenture Holders whereby the Debenture Holders agreed to convert a total of $742,135 in principal and original issue discount due to them under the Debentures into 296.80 shares of Series AA Convertible Preferred Stock with a conversion price of $2.50 per share. The Debenture Holders were also: (a) issued amended Debenture Warrants such that the exercise price will be $3.50 per share; and (b) issued a new warrant with an exercise price of $3.50 per share to purchase 296,800 shares of common stock (the number of shares of common stock issuable upon conversion of the Series AA Convertible Preferred Stock shares received as a result of the Debenture conversions). The Debenture Holders also agreed to waive any and all defaults or events of default by the Company with respect to any failure by the Company to comply with any covenants contained in the Debentures. The fair value of $3,155 relating to the adjustment in exercise price was treated as a loan modification and recorded as a gain toward the extinguishment of debt.

 

In connection with the above Debenture conversions and cancellation of the debt term, the Company recorded the full amount of the remaining unamortized Debenture discounts of $157,908 as interest expense by June 11, 2018. The Company recorded $287,676 of the Debenture discounts during 2018 through the cancellation date of June 11, 2018.

 

On various dates for the nine months ended September 30, 2018, the Company issued 56,007 shares of common stock based on the 10-day VWAP prior to quarter end to holders of the Debentures in payment of the quarterly interest accrued from the Debentures first anniversary date through December 31, 2017 for an aggregate amount of $211,047. We recognized a $9,615 gain on extinguishment of debt by calculating the difference of the shares valued on the issuance date and the amount of accrued interest through June 11, 2018.

 

Convertible notes

 

The Company, pursuant to a price protection provision triggered on May 2, 2018 with the sale of Series AA Convertible Preferred Stock, amended the conversion price of a March 12, 2018 loan to $2.50 per share. The fair value of $253,000, limited to the face value of the loan, relating to the reset in the conversion price was recorded as a debt discount and amortized as interest expense over the remaining loan term.

 

On various dates during the nine months ended September 30, 2019, the Company issued convertible notes for net proceeds of approximately $4.6 million which contained varied terms and conditions as follows: a) maturity dates ranging from 2 to 12 months; b) interest rates that accrue per annum ranging from 3% to 15%; c) convertible into the Company’s common stock at issuance at a fixed rate of $2.50 to $7.50 or convertible at variable conversion rates either after 6 months after issuance or in the event of a default. Certain of these notes were issued with shares of common stock that were fair valued at issuance dates. The aggregate relative fair value of $226,133 of the shares of common stock issued with the notes was recorded as a debt discount and amortized over the term of the notes. During the nine months ended September 30, 2019 we also have evaluated our convertible notes (upon issuance or modification) for any beneficial conversion feature (“BCF”), reporting the BCF as additional paid in capital and debt discount of $451,665. Finally, we evaluate the convertible notes for derivative liability treatment on an on-going basis and have determined that all our notes did not qualify for derivative accounting treatment as of September 30, 2019. In this period, the amortization of this debt discount was $362,056 and as of September 30, 2019 the unamortized BCF debt discount was $89,610.

 

The specific terms of the convertible notes that are outstanding as of September 30, 2019 are listed in the tables below.

 

Loan

Inception Date

  Term     Loan Amount     Outstanding Balance with OID     Original Issue Discount     Interest Rate     Conversion Price     Deferred Finance Fees     Discount related to fair value of conversion feature and warrants/shares  
February 15, 2018 (1),(2),(3)     6 months     $ 100,000     $ 115,000               15 %   $ 2.5     $ 9,000     $ 14,106  
May 17, 2018 (1),(2)     12 months     $ 380,000     $ 191,703     $ 15,200       8 %   $ 2.5     $ 15,200     $ 188,007  
May 30, 2018 (1),(2)     2 months     $ 150,000     $ 75,000     $ -       8 %   $ 7.5     $ -     $ 6,870  
June 8, 2018 (1)     6 months     $ 50,000     $ 50,000     $ 2,500       15 %   $ 7.5     $ 2,500     $ 3,271  
June 12, 2018 (1)     6 months     $ 100,000     $ 100,000     $ -       5 %   $ 7.5     $ 5,000     $ -  
June 16, 2018 (1)     9 months     $ 130,000     $ 79,000     $ -       5 %   $ (4 )    $ -     $ -  
June 16, 2018 (1)     6 months     $ 110,000     $ 79,000     $ -       5 %   $ (4 )    $ -     $ -  
June 26, 2018 (1),(3)     3 months     $ 150,000     $ 86,250     $ -       15 %   $ 2.5     $ -     $ 25,507  
June 28, 2018 (1)     6 months     $ 50,000     $ 50,000     $ -       15 %   $ 7.5     $ -     $ 10,518  
July 17, 2018 (1),(3)     3 months     $ 100,000     $ 105,000     $ 15,000       15 %   $ 2.5     $ -     $ 46,597  
July 19, 2018 (1)     12 months     $ 184,685     $ 150,000     $ 34,685       10 %   $ 7.5     $ -     $ -  
October 19, 2018 (1),(2)     6 months     $ 100,000     $ 100,000     $ -       5 %   $ 7.5     $ -     $ -  
November 13, 2018 (1),(3)     6 months     $ 200,000     $ 220,000     $ -       15 %   $ 2.5     $ -     $ 99,330  
January 2, 2019     12 months     $ 125,000     $ 112,500     $ -       4 %   $ 2.5     $ 6,250     $ 6,620  
January 3, 2019 (1)     6 months     $ 50,000     $ 50,000     $ 2,500       15 %   $ 7.5     $ 2,500     $ -  
February 21, 2019     12 months     $ 215,000     $ 215,000     $ -       4 %   $ 2.75     $ 15,000     $ 96,764  
February 22, 2019     9 months     $ 115,563     $ 115,562     $ 8,063       7 %   $ 7.5     $ 2,500     $ -  
March 18, 2019 (2)     6 months     $ 100,000     $ 100,000     $ -       4 %   $ 7.5     $ -     $ 10,762  
June 4, 2019     9 months     $ 500,000     $ 500,000     $ -       8 %   $ 2.5     $ 40,500     $ 70,631  
May 15, 2019     12 months     $ 75,000     $ 75,000     $ 7,500       5 %     (4 )   $ 2,000     $ 4,235  
May 28, 2019     12 months     $ 115,500     $ 115,500     $ 5,500       8 %   $ 2.75     $ -     $ 22,354  
May 14, 2019     12 months     $ 100,000     $ 100,000     $ -       6 %   $ 7.5     $ 2,000     $ -  
April 30, 2019     12 months     $ 105,000     $ 105,000     $ -       4 %   $ 7.5     $ 5,000     $ 3,286  
June 19, 2019     12 months     $ 105,000     $ 105,000     $ -       4 %   $ 7.5     $ 5,000     $ 2,646  
April 9, 2019     12 months     $ 118,800     $ 118,800     $ 8,800       4 %   $ 7.5     $ 3,000     $ -  
May 6, 2019     12 months     $ 150,000     $ 150,000     $ -       6 %   $ 7.5     $ 7,500     $ 3,534  
May 7, 2019     6 months     $ 155,000     $ 155,000     $ 5,000       0 %   $ 7.5     $ -     $ 12,874  
April 23, 2019     10 months     $ 103,000     $ 103,000     $ -       8 %     (4 )   $ 3,000     $ -  
May 17, 2019     10 months     $ 103,000     $ 103,000     $ -       8 %     (4 )   $ 3,000     $ -  
April 10, 20 19 (1),(3)     3 months     $ 75,000     $ 86,250     $ -       5 %   $ 2.5     $ -     $ 37,054  
May 20, 2019 (1)     3 months     $ 100,000     $ 100,000     $ -       5 %   $ 2.5     $ -     $ 13,439  
June 7, 2019     6 months     $ 125,000     $ 125,000     $ -       5 %   $ 7.5     $ -     $ 18,254  
July 1, 2019     12 months     $ 107,500     $ 107,500     $ -       4 %   $ 4.0     $ 7,500     $ 11,246  
July 8, 2019     12 months     $ 65,000     $ 65,000     $ -       5 %     (4 )   $ 8,500     $ 4,376  
July 10, 2019     9 months     $ 112,500     $ 112,500     $ -       8 %     (4 )   $ 3,000     $ -  
July 19, 2019     6 months     $ 250,000     $ 250,000     $ -       4 %   $ 7.5     $ -     $ 36,835  
July 19, 2019     12 months     $ 115,000     $ 115,000     $ -       4 %   $ 7.5     $ 5,750     $ 3,989  
July 19, 2019     12 months     $ 130,000     $ 130,000     $ -       6 %   $ 7.5     $ 6,500     $ -  
August 6, 2019     12 months     $ 108,000     $ 108,000     $ -       4 %   $ 7.5     $ 11,000     $ -  
August 14, 2019     6 months     $ 50,000     $ 50,000     $ -       3 %   $ 7.5     $ -     $ -  
August 27, 2019     10 months     $ 113,000     $ 113,000     $ -       8 %     (4 )   $ 3,000     $ -  
September 11, 2019     12 months     $ 50,000     $ 50,000     $ -       6 %     (4 )   $ 6,500     $ 3,823  
September 13, 2019     12 months     $ 100,000     $ 100,000     $ -       6 %   $ 2.50     $ 2,000     $ -  
September 27, 2019     12 months     $ 78,750     $ 78,750     $ -       4 %   $ 2.50     $ 3,750     $ 13,759  
                                                                 
            $ 5,620,298     $ 5,215,315     $ 104,748                     $ 186,450     $ 770,687  

 

(1) The notes were extended for an additional term.

(2) The note is currently past due. The Company and the lender are negotiating in good faith to extend the loan.

(3) Interest was capitalized and added to outstanding principal amount.

(4) Note is not currently convertible.

 

For the nine months ended September 30, 2019, the Company recognized amortization expense related to the debt discounts indicated above of $830,181. The unamortized debt discounts as of September 30, 2019 related to the convertible debentures and other convertible notes amounted to $326,380.

 

Revolving Note Payable and May 19, 2017 Promissory Note

 

On October 28, 2016, an accredited investor (the “Investor”) purchased from us a promissory note in the aggregate principal amount of up to $2,000,000 (the “Revolving Note”) due and payable on the earlier of October 28, 2017 (the “Maturity Date”) or on the seventh business day after the closing of a Qualified Offering (as defined in the Revolving Note). Although the Revolving Note is dated October 26, 2016, the transaction did not close until October 28, 2016, when we received its initial $250,000 advance pursuant to the Revolving Note. As a result, on the same day and pursuant to the Revolving Note, we issued to the Investor a Common Stock Purchase Warrant to purchase 20,834 shares of our common stock at an exercise price per share equal to $12.00 per share. The Investor is obligated to provide us with advances of $250,000 under the Revolving Note, but the Investor shall not be required to advance more than $250,000 in any individual fifteen (15) day period and no more than $500,000 in the thirty (30) day period immediately following the date of the initial advance. We received $3,500,000 pursuant to the Revolving Note as amended of which $2,070,000 net proceeds was received in 2017 and we issued to the Investor warrants to purchase 291,667 shares of our Common Stock at an exercise price per share equal to $12.00 per share. The terms of the Warrants are identical except for the exercise date, issue date, and termination date which are based on the advance date.

 

The Revolving Note was amended on May 2, 2017 to increase the aggregate principal amount to $3,000,000, to issue 16,667 shares of our Common Stock to the Investor, to decrease the exercise price per share of the warrants to the lower of (i) $12.00 or (ii) the per share purchase price of the shares of our Common Stock sold in the Qualified Offering, and to change the references in the Revolving Note from “the six (6) month anniversary of October 28, 2016” to “July 25, 2017.” The fair value of the 16,667 shares issued of $149,018 was accounted for as a note discount and are amortized to interest expense over the life of the loan. We evaluated the accounting impact of the Revolving Note amendment and deemed that the amendment did not have a material impact on our consolidated financial statements.

 

The Revolving Note was amended on August 18, 2017 to increase the aggregate principal amount to $3,500,000 with all other terms unchanged. The Revolving Note, previously amended, was further amended on January 30, 2018 to increase the aggregate principal amount to $4,000,000 with all other terms unchanged.

 

In the event that a Qualified Offering had occurred after July 25, 2017, but prior to the Maturity Date, within seven (7) Business Days of the closing of the Qualified Offering, the Company was to pay a cash fee equal to five percent (5%) of the total outstanding amount owed by the Company to the Holder as of the closing date of the Qualified Offering or, at the option of the Company, issue to the Holder a number of restricted shares of the Company’s common stock equal to (x) five percent (5%) of the total outstanding amount owed by the Company to the Holder as of the closing date of the Qualified Offering divided by (y) the purchase price provided by the documents governing the Qualified Offering. A “Qualified Offering” means the completion of a public offering of the Company’s securities pursuant to which the Company receives aggregate gross proceeds of at least Seven Million United States Dollars (US$7,000,000) in consideration of the purchase of its securities and resulting in, pursuant to the effectiveness of the registration statement for such offering, the Company’s common stock being traded on the NASDAQ Capital Market, NASDAQ Global Select Market or the New York Stock Exchange. A Qualified Offering did not occur on or prior to the Maturity Date.

 

Interest on the principal balance of the Revolving Note and fees of $95,000 were converted into 38 shares of Series AA Convertible Preferred Stock with a conversion price of $2.50 per share as discussed below.

 

Broker fees amounting to $336,500, the one-time interest of $400,000 and the relative fair value of the 333,334 warrants issued to the Investor amounting to $1,266,691 were recorded as debt discounts and amortized over the term of the revolving note. The unamortized debt discounts related to the Revolving Note were fully amortized as of December 31, 2017. The finance costs from advances after December 31, 2017 were charged to interest expense directly because the maturity date had passed.

 

On May 19, 2017, we received a 45-day non-convertible loan of $630,000 from the Investor. The loan provided guaranteed interest of $63,000 and had an origination fee of $32,000. We paid a broker $31,500 in connection with this loan.

 

Conversion of October 26, 2016 Revolving Note and May 19, 2017 Promissory Note

 

On June 11, 2018, the Company entered into a Letter Agreement with the Investor to convert a total of $5,500,000 in principal and interest due to the Investor pursuant to the Revolving Note and the May 19, 2017 promissory note into 2,200 shares of Series AA Convertible Preferred Stock with a conversion price of $2.50 per share. The Company also amended the Line of Credit Warrants held by the Investor. The Company lowered the Line of Credit Warrants’ exercise price from $12.00 per share to $3.50 per share. The fair value of $82,904 relating to the reduction in exercise price was treated as a loan modification and recorded as a charge against the extinguishment of debt.

 

The Company also issued a new warrant to the Investor with an exercise price of $3.50 per share to purchase 2,200,000 shares of common stock (the number of shares of common stock issuable upon conversion of the Series AA Convertible Preferred Stock shares received as a result of the conversion of a total of $5,500,000). In connection with the Letter Agreement, the Investor also waived $520,680 of interest and fees owed as of September 30, 2018. We recognized $520,680 as a gain on extinguishment of debt.

 

Convertible Loan Modifications and Extinguishments

 

We refinanced certain convertible loans during the nine months ended September 30, 2019 at substantially the same terms for extensions of ranging from three to six months. We amortized any remaining unamortized debt discount as of the modification date over the remaining, extended term of the new loans. We applied ASC 470 of modification accounting to the debt instruments which were modified during the quarter or those settled with new notes issued concurrently for the same amounts but different maturity dates. The terms such as the interest rate, prepayment penalties, and default rates will be the same over the new extensions. According to ASC 470, an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different if the present value of the cash flows under the terms of the new debt instrument is at least 10 percent different from the present value of the remaining cash flows under the terms of the original instrument. If the terms of a debt instrument are changed or modified and the cash flow effect on a present value basis is less than 10 percent, the debt instruments are not considered to be substantially different and will be accounted for as modifications.

 

The cash flows of new debt exceeded 10% of the remaining cash flows of the original debt on seventeen loans in the nine months of 2019. We recorded losses on debt extinguishment of $332,474 for the nine months ended September 30, 2019 by calculating the difference of the fair value of the new debt and the carrying value of the old debt. The loss was primarily from the fair value of common stock issued in connection with these refinancings and cash fees paid.

 

On various dates in the nine months ended September 30, 2019, two lenders converted $300,000 of amounts owed into 120,000 shares of common stock. The amount converted included $200,797 of principal and $141,453 of interest and fees.

 

The Company’s Chief Executive Officer is personally guaranteeing $190,000 of convertible debt of which $190,000 is outstanding as of September 30, 2019.

 

The following table provides a summary of the changes in convertible debt and revolving note payable, net of unamortized discounts, during 2019:

 

    2019  
Balance at January 1,   $ 4,000,805  
Issuance of convertible debt, face value     4,964,613  
Deferred financing cost     (285,813 )
Debt discount from shares issued with the notes     (262,904 )
Contingent BCF on convertible notes     (451,665 )
Conversion of debt into equity     (200,797 )
Payments     (3,705,485 )
Accretion of interest and amortization of debt discount to interest expense     830,181  
Balance at September 30,   $ 4,888,935  
Less: current portion     4,888,935  
Convertible debt, long-term portion   $ -  

 

Other Notes

 

In March 2018, we received non-convertible loans totaling $150,000 from private investors. The loans include one-year term and 10% guaranteed interest. We converted these loans into Series AA Convertible Preferred Stock and common stock warrants. See below.

 

In April 2018, we received a non-convertible loan for $10,000 from a private investor. The loan includes a one-year term and 10% guaranteed interest. We converted this loan into Series AA Convertible Preferred Stock and common stock warrants. See below.

 

As further disclosed on page 24, during the nine months ended September 30, 2019 we signed various Merchant Agreements which are secured by second position rights to all customer receipts until the loan has been repaid in full and subject to interest rates from 31% to 47%. Under the terms of these agreements, we received the disclosed Purchase Price and agreed to repay the disclosed Purchase Amount, which is collected by the Merchant lenders at the disclosed Daily Payment Rate.

 

On September 9, 2019, we received a non-convertible loan for $400,000 from a private investor. The loan includes $95,000 of interest and fees through October 9, 2019. The loan is currently past due and the Company and the Investor are negotiating in good faith to extend the loan including interest and late fees owed.

 

On October 1, 2019, the Company and the holder of the $170,000 convertible loan issued in May 2017 agreed to extend the terms of the loan until December 31, 2019. The Company agreed to issue 1,200 shares of its common stock per month while the note remains outstanding. The loan will continue to earn 10% annual interest.

 

Merchant Agreements

 

We have signed various Merchant Agreements which entitle the lenders to our customer receipts. We accounted for the Merchant Agreements as loans under ASC 860 because while we provided rights to current and future receipts, we still had control over the receipts. Under the agreements below we received the Purchase Price, of which approximately in exchange for rights to all customer receipts until the lender is paid the Purchased Amount, which is collected at the rate of the Daily Payment per business day. The difference between the Purchased Amount and Purchase price is imputed interest that will be recorded as interest expense when paid each day. The Deferred Finance fees below were paid on the inception date. The payments were secured by second position rights to all customer receipts until the loan has been paid in full.

 

The following table shows our Merchant Agreements as of September 30, 2019.

 

Inception Date   Purchase
Price
    Purchased
Amount
    Outstanding
Balance
    Daily
Payment
Rate
    Deferred
Finance Fees
 
August 5, 2019     600,000       816,000       503,439       4,533.33       6,000  
August 19, 2019     350,000       479,500       309,565       2,664.00       3,000  
August 23, 2019     175,000       239,750       158,321       1,410.00       1,750  
September 19, 2019     275,000       384,275       273,948       2,137.36       5,000  
                                         
    $ 1,400,000     $ 1,919,525     $ 1,245,273             $ 15,750  

 

See Note 8, Subsequent Events.

 

We amortized $31,797 and $56,769 of debt discounts during the nine months ended September 30, 2019 and 2018, respectively for all non-convertible notes. The total unamortized discount for all non-convertible notes as of September 30, 2019 was $7,036.

 

The Company’s Chief Executive Officer is personally guaranteeing $1,245,273 of loans outstanding as of September 30, 2019. These loans include debt through certain merchant agreements.

 

Conversion of Non-Convertible Notes

 

On June 11, 2018, the Company entered into Letter Agreements with certain private investors to convert a total of $176,000 in principal and interest due to the private investors pursuant to certain loan documents into 70.4 shares of Series AA Convertible Preferred Stock with a conversion price of $2.50 per share and warrants to purchase 70,400 shares of common stock and an expiration period of five years from the original issue date.

 

Related Party Notes

 

In June 2018, we received a non-convertible loan of $15,000 from a private investor. The loan includes a one-year term and 10% guaranteed interest. This loan remains outstanding as of September 30, 2019.

 

During the nine months ended September 30, 2019, we received short-term non-convertible loans of $239,000 from related parties (a member of the Company’s Board of Directors and Company Officers). The loans were repaid in full as of September 30, 2019 except for $79,000.